Literature DB >> 24227780

BANK1 controls CpG-induced IL-6 secretion via a p38 and MNK1/2/eIF4E translation initiation pathway.

Ying-Yu Wu1, Ramesh Kumar, Mohammed Shamsul Haque, Casimiro Castillejo-López, Marta E Alarcón-Riquelme.   

Abstract

BANK1, an adaptor protein expressed in B cells, plays a little understood role in B cell signaling. Because BANK1 contains an N-terminal putative Toll/IL-1R receptor domain, we used mouse Bank1(-/-) splenic B cells to test whether BANK1 affects signaling induced by the TLR9 agonist CpG. Following CpG stimulation, BANK1 deficiency reduced p38 phosphorylation without affecting that of ERK or JNK and reduced IL-6 secretion. Bank1(-/-) B cells showed reduced phosphorylation of MNK1/2 and eIF4E, suggesting an effect on translation initiation, whereas Bank1(-/-) had no effect on IL-6 mRNA stability, thus suggesting that BANK1 has no effect on MK2 signaling. IL-6 secretion observed when CpG stimulation was combined with anti-CD40 was reduced in the absence of BANK1. Whereas in the presence of anti-CD40 stimulation CpG induced a stronger phosphorylation of AKT, mTOR, and 4E-BP1, Bank1(-/-) had no effect on phosphorylation of mTOR and 4E-BP1, and a weak effect on AKT, implying that BANK1 does not affect the release of eIF4E by phospho-4E-BP1. Taken together, these data establish a previously unrecognized role for BANK1 in CpG-induced responses by splenic B cells on p38 signaling and control of translation initiation of IL-6 via MNK1/2 and eIF4E.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24227780      PMCID: PMC3858538          DOI: 10.4049/jimmunol.1301203

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.

Authors:  Nadia L Bernasconi; Nobuyuki Onai; Antonio Lanzavecchia
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

2.  Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals.

Authors:  Giuliana Cassese; Sergio Arce; Anja E Hauser; Katja Lehnert; Beate Moewes; Miro Mostarac; Gwendolin Muehlinghaus; Martin Szyska; Andreas Radbruch; Rudolf A Manz
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

3.  BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor.

Authors:  Kazumasa Yokoyama; I-hsin Su Ih; Tohru Tezuka; Tomoharu Yasuda; Katsuhiko Mikoshiba; Alexander Tarakhovsky; Tadashi Yamamoto
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

4.  The dual effect of the lupus-associated polymorphism rs10516487 on BANK1 gene expression and protein localization.

Authors:  S V Kozyrev; M Bernal-Quirós; M E Alarcón-Riquelme; C Castillejo-López
Journal:  Genes Immun       Date:  2011-09-08       Impact factor: 2.676

5.  CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.

Authors:  Eriko Saito; Manabu Fujimoto; Minoru Hasegawa; Kazuhiro Komura; Yasuhito Hamaguchi; Yuko Kaburagi; Tetsuya Nagaoka; Kazuhiko Takehara; Thomas F Tedder; Shinichi Sato
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

6.  Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells.

Authors:  Sangeeta Banerjee; Krishna Narayanan; Tetsuya Mizutani; Shinji Makino
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation.

Authors:  Sokol A Haxhinasto; Gail A Bishop
Journal:  J Biol Chem       Date:  2003-11-06       Impact factor: 5.157

8.  Affinity purification of ARE-binding proteins identifies polyA-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization.

Authors:  Frank Bollig; Reinhard Winzen; Matthias Gaestel; Susanne Kostka; Klaus Resch; Helmut Holtmann
Journal:  Biochem Biophys Res Commun       Date:  2003-02-14       Impact factor: 3.575

9.  B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.

Authors:  Tom A Barr; Ping Shen; Sheila Brown; Vicky Lampropoulou; Toralf Roch; Sarah Lawrie; Boli Fan; Richard A O'Connor; Stephen M Anderton; Amit Bar-Or; Simon Fillatreau; David Gray
Journal:  J Exp Med       Date:  2012-04-30       Impact factor: 14.307

10.  B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1.

Authors:  Alex Karnowski; Stephane Chevrier; Gabrielle T Belz; Adele Mount; Dianne Emslie; Kathy D'Costa; David M Tarlinton; Axel Kallies; Lynn M Corcoran
Journal:  J Exp Med       Date:  2012-10-08       Impact factor: 14.307

View more
  18 in total

1.  p38α regulates cytokine-induced IFNγ secretion via the Mnk1/eIF4E pathway in Th1 cells.

Authors:  María Salvador-Bernáldez; Sara B Mateus; Iván Del Barco Barrantes; Simon C Arthur; Carlos Martínez-A; Angel R Nebreda; Jesús M Salvador
Journal:  Immunol Cell Biol       Date:  2017-06-14       Impact factor: 5.126

Review 2.  Regulation of senescence traits by MAPKs.

Authors:  Carlos Anerillas; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Geroscience       Date:  2020-04-16       Impact factor: 7.713

3.  The BANK1 SLE-risk variants are associated with alterations in peripheral B cell signaling and development in humans.

Authors:  Elizabeth M Dam; Tania Habib; Janice Chen; Andrew Funk; Veronika Glukhova; Mel Davis-Pickett; Shan Wei; Richard James; Jane H Buckner; Karen Cerosaletti
Journal:  Clin Immunol       Date:  2016-11-02       Impact factor: 3.969

4.  The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis.

Authors:  Tim Fugmann; Adriana Sofron; Danilo Ritz; Franziska Bootz; Dario Neri
Journal:  J Immunol       Date:  2016-12-23       Impact factor: 5.422

5.  MNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL.

Authors:  Ari L Landon; Parameswary A Muniandy; Amol C Shetty; Elin Lehrmann; Laurent Volpon; Simone Houng; Yongqing Zhang; Bojie Dai; Raymond Peroutka; Krystyna Mazan-Mamczarz; James Steinhardt; Anup Mahurkar; Kevin G Becker; Katherine L Borden; Ronald B Gartenhaus
Journal:  Nat Commun       Date:  2014-11-18       Impact factor: 14.919

Review 6.  TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells.

Authors:  Amy N Suthers; Stefanie Sarantopoulos
Journal:  Front Immunol       Date:  2017-07-13       Impact factor: 7.561

7.  Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis.

Authors:  Daniel Toro-Domínguez; Pedro Carmona-Sáez; Marta E Alarcón-Riquelme
Journal:  Arthritis Res Ther       Date:  2017-03-11       Impact factor: 5.156

Review 8.  The Role of BANK1 in B Cell Signaling and Disease.

Authors:  Gonzalo Gómez Hernández; María Morell; Marta E Alarcón-Riquelme
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

9.  Variants in BANK1 are associated with lupus nephritis of European ancestry.

Authors:  Karin Bolin; Juliana Imgenberg-Kreuz; Dag Leonard; Johanna K Sandling; Andrei Alexsson; Pascal Pucholt; Malena Loberg Haarhaus; Jonas Carlsson Almlöf; Joanne Nititham; Andreas Jönsen; Christopher Sjöwall; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Elisabet Svenungsson; Iva Gunnarsson; Ann-Christine Syvänen; Karoline Lerang; Anne Troldborg; Anne Voss; Øyvind Molberg; Søren Jacobsen; Lindsey Criswell; Lars Rönnblom; Gunnel Nordmark
Journal:  Genes Immun       Date:  2021-06-14       Impact factor: 2.676

10.  BANK1 Regulates IgG Production in a Lupus Model by Controlling TLR7-Dependent STAT1 Activation.

Authors:  Ying-Yu Wu; Ramesh Kumar; Ryuji Iida; Harini Bagavant; Marta E Alarcón-Riquelme
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.